Our research has resulted in numerous publications, honors, and awards and has been presented in seven countries.

More importantly, it allows us to improve our methods so that we attain some of the best IVF success rates in the United States, helping more couples to realize their dream of bringing home a healthy baby.

Most Recent:

Recurrent implantation failure is another indication for the freeze-all strategy.

Published: Fertility and Sterility 2017.

Comparison of birthweights in patients randomly assigned to fresh or frozen-thawed embryo transfer.

Published: Fertility and Sterility 2016.

Freeze-all at the blastocyst or bipronuclear stage: A randomized clinical trial.

Published: Fertility and Sterility 2015.

The risks of embryo-endometrium asynchrony increase with maternal age after ovarian stimulation and IVF.

Published: Reproductive Biomedicine Online 2015.

A large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization. 

Published: Fertility and Sterility 2015.

Major drawbacks and additional benefits of agonist trigger—not ovarian hyperstimulation syndrome related,

Published: Fertility and Sterility 2015.

Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer,

Published: Fertility and Sterility 2014.

Freeze-all can be a superior therapy to another fresh cycle in patients with prior fresh blastocyst implantation failure,

Published: Reproductive Biomedicine Online 2014.

Matched-cohort comparison of signal-embryo transfers in fresh and frozen-thawed embryo transfer cycles.

Published: Fertility and Sterility June 2012. National Center for Biotechnology Information October 2012.

Frozen-thawed embryo transfer is associated with a significantly reduced incidence of ectopic pregnancy.

Published: Fertility and Sterility June 2012. National Center for Biotechnology Information December 2012.

Serum HCG measured in the peri-implantation period predicts IVF cycle outcomes

Published: December 2011 Reproductive BioMedicine Online. National Center for Biotechnology Information September 2012.

Past Favorites:

Similar ongoing pregnancy rates after blastocyst transfer in fresh donor cycles and autologous cycles using cryopreserved bipronuclear oocytes suggest similar viability of transferred blastocysts

Published: Fertility and Sterility March 19 2009. National Center for Biotechnology Information January 2010.

Embryo cryopreservation rescues cycles with premature luteinization.

Published: National Center for Biotechnology Information February 2010.

Comparison of “triggers” using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin

Published: Fertility and Sterility March 2011. National Center for Biotechnology Information June 2011.

Efficacy of induced luteinizing hormone surge after “trigger” with gonadotropin-releasing hormone agonist.

Published: National Center for Biotechnology Information February 2011. Fertility and Sterility May 2010.

Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony

Published: Fertility and Sterility January 2006. National Center for Biotechnology Information January 2008.